Jiangsu Aidea Pharmaceutical Co Ltd (688488) — Cash Flow-to-Debt Ratio
Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥3.56 Million could theoretically repay 0% of its total liabilities (CN¥762.97 Million) in one year. See financial flexibility index of Jiangsu Aidea Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu Aidea Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Jiangsu Aidea Pharmaceutical Co Ltd across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Jiangsu Aidea Pharmaceutical Co Ltd.
Annual Cash Flow-to-Debt Ratio for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2025)
Year-by-year debt coverage analysis for Jiangsu Aidea Pharmaceutical Co Ltd. Check Jiangsu Aidea Pharmaceutical Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | CN¥17.63 Million | CN¥839.37 Million | ▲ +145.0% |
| 2024 | -0.05x | CN¥-37.50 Million | CN¥802.48 Million | ▲ +82.5% |
| 2023 | -0.27x | CN¥-166.22 Million | CN¥621.03 Million | ▼ -31.9% |
| 2022 | -0.20x | CN¥-92.55 Million | CN¥456.23 Million | ▼ -104.7% |
| 2021 | -0.10x | CN¥-12.37 Million | CN¥124.82 Million | ▼ -115.3% |
| 2020 | 0.65x | CN¥56.17 Million | CN¥86.97 Million | ▲ +158.3% |
| 2019 | 0.25x | CN¥56.20 Million | CN¥224.74 Million | ▲ +239.0% |
| 2018 | -0.18x | CN¥-33.50 Million | CN¥186.24 Million | ▲ +61.1% |
| 2017 | -0.46x | CN¥-67.18 Million | CN¥145.14 Million | ▼ -311.8% |
| 2016 | 0.22x | CN¥31.29 Million | CN¥143.16 Million | — |